Celecoxib increases retinoid sensitivity in human colon cancer cell lines

Retinoid resistance has limited the clinical application of retinoids as differentiation-inducing and apoptosis-inducing drugs. This study was designed to investigate whether celecoxib, a selective COX-2 inhibitor, has effects on retinoid sensitivity in human colon cancer cell lines, and to determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jian-Pei, Wei, Hong-Bo, Zheng, Zong-Heng, Guo, Wei-Ping, Fang, Jia-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SP Versita 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275995/
https://www.ncbi.nlm.nih.gov/pubmed/20496179
http://dx.doi.org/10.2478/s11658-010-0016-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275995/
https://www.ncbi.nlm.nih.gov/pubmed/20496179
http://dx.doi.org/10.2478/s11658-010-0016-2

Ejemplares similares